Status:
COMPLETED
Impact of Human Embryo Culture System on Live Birth
Lead Sponsor:
Vida Recoletas Sevilla
Conditions:
Embryo Culture
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
Previous studies in human and different mammals have proved that the embryo group culture (in the same culture medium drop) using a reduced volume is associated with a better embryo development. This ...
Eligibility Criteria
Inclusion
- \<38 years (with own oocytes) / \<45 years (with oocyte donation).
- First treatment with own oocytes / any treatment with oocyte donation.
- ≥10 oocytes with a diameter of ≥10 mm.
Exclusion
- Diseases that affect endometrial receptivity: endometriosis, hydrosalpinx, ovarian hyperstimulation syndrome, obesity, endocrinopathies, thrombophilia, congenital or acquired uterine anomalies.
- Patients under a treatment with genetic preimplantation diagnosis.
Key Trial Info
Start Date :
July 23 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT01904006
Start Date
July 23 2013
End Date
October 1 2016
Last Update
April 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Sevilla
Seville, Seville, Spain, 41011